Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Kombinierte familiäre Hyperlipämie mit gestörtem VLDL-Metabolismus

Die kombinierte familiäre Hyperlipämie mit gestörtem VLDL-Metabolismus beinhalted Fettstoffwechselstörungen, bei denen die Mutationen zu einer verzögerten Elimination von VLDL aus dem Plasma führen.

Gliederung

Familiäre kombinierte Hyperlipämie
Kombinierte familiäre Hyperlipämie mit Dysfunktion des Fettgewebes
Kombinierte familiäre Hyperlipämie mit VLDL-Überproduktion
Kombinierte familiäre Hyperlipämie mit gestörtem VLDL-Metabolismus
ANGPTL8
APOA1
APOA4
APOA5
APOC3
CETP
GALNT2
LCAT
LIPC
LIPG
LPL
RXRG
USF1
Kombinierte familiäre Hyperlipämie mit gestörter LDL-Clearance

Referenzen:

1.

DeMattos RB et al. (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

external link
2.

Dodart JC et al. (2005) Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.

external link
3.

Schächter F et al. (1994) Genetic associations with human longevity at the APOE and ACE loci.

external link
4.

Kadotani H et al. (2001) Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults.

external link
5.

Spirin V et al. (2007) Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol.

external link
6.

Kathiresan S et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events.

external link
7.

Aulchenko YS et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.

external link
8.

Sparkes RS et al. (1987) Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21.

external link
9.

Magoori K et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.

external link
10.

Greenberg SM et al. (1995) Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

external link
11.

Nicoll JA et al. (1996) High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy.

external link
12.

Yamada M et al. (1996) Lack of an association between apolipoprotein E epsilon 4 and cerebral amyloid angiopathy in elderly Japanese.

external link
13.

Nicoll JA et al. (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.

external link
14.

Greenberg SM et al. (1998) Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

external link
15.

O'Donnell HC et al. (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.

external link
16.

Evans D et al. (2005) Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.

external link
17.

Benlian P et al. (1996) Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.

external link
18.

Burt TD et al. (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

external link
19.

Kawashiri MA et al. (2005) Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

external link
20.

Henderson HE et al. (1991) Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.

external link
21.

Emi M et al. (1990) Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency.

external link
22.

Chen Y et al. (2008) Variations in DNA elucidate molecular networks that cause disease.

external link
23.

Feussner G et al. (1996) Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.

external link
24.

Henderson HE et al. (1992) The lipoprotein lipase Gly188----Glu mutation in South Africans of Indian descent: evidence suggesting common origins and an increased frequency.

external link
25.

Hata A et al. (1992) Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization.

external link
26.

Normand T et al. (1992) Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Québec.

external link
27.

Sprecher DL et al. (1992) Trp64----nonsense mutation in the lipoprotein lipase gene.

external link
28.

Chimienti G et al. (1992) A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family.

external link
29.

Gotoda T et al. (1992) A newly identified null allelic mutation in the human lipoprotein lipase (LPL) gene of a compound heterozygote with familial LPL deficiency.

external link
30.

Bergeron J et al. (1992) Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.

external link
31.

Ishimura-Oka K et al. (1992) A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.

external link
32.

Ma Y et al. (1992) A missense mutation (Asp250----Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestries.

external link
33.

Heizmann C et al. (1991) DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels.

external link
34.

Dichek HL et al. (1991) Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome.

external link
35.

Kobayashi J et al. (1992) A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.

external link
36.

Takagi A et al. (1992) Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript.

external link
37.

Gotoda T et al. (1991) Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.

external link
38.

Paulweber B et al. (1991) Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.

external link
39.

Faustinella F et al. (1991) Catalytic triad residue mutation (Asp156--Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447--Ter) in a Turkish family.

external link
40.

De Braekeleer M et al. (1991) Founder effect in familial hyperchylomicronemia among French Canadians of Quebec.

external link
41.

Monsalve MV et al. (1990) A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.

external link
42.

Ameis D et al. (1991) Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.

external link
43.

Ma Y et al. (1991) A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.

external link
44.

Beg OU et al. (1990) Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.

external link
45.

Hata A et al. (1990) Compound heterozygote for lipoprotein lipase deficiency: Ser--Thr244 and transition in 3' splice site of intron 2 (AG--AA) in the lipoprotein lipase gene.

external link
46.

Devlin RH et al. (1990) Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.

external link
47.

Emi M et al. (1990) Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene.

external link
48.

Wilson DE et al. (1990) Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

external link
49.

Langlois S et al. (1989) A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency.

external link
50.

Kirchgessner TG et al. (1989) Organization of the human lipoprotein lipase gene and evolution of the lipase gene family.

external link
51.

Deeb SS et al. (1989) Structure of the human lipoprotein lipase gene.

external link
52.

Heinzmann C et al. (1987) RFLP for the human lipoprotein lipase (LPL) gene: HindIII.

external link
53.

Funke H et al. (1987) Hind III RFLP in the lipoprotein lipase gene, (LPL).

external link
54.

Li SR et al. (1988) Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus.

external link
55.

Funke H et al. (1988) Bst NI (Eco RII) RFLP in the lipoprotein lipase gene (LPL).

external link
56.

Kirchgessner TG et al. (1987) The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family.

external link
57.

Wion KL et al. (1987) Human lipoprotein lipase complementary DNA sequence.

external link
58.

Wilson DE et al. (1983) Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.

external link
59.

Levak-Frank S et al. (1995) Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

external link
60.

Yang WS et al. (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.

external link
61.

Lo JY et al. (1995) Lipoprotein lipase: role of intramolecular disulfide bonds in enzyme catalysis.

external link
62.

Ma Y et al. (1994) Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries.

external link
63.

Emi M et al. (1993) Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene.

external link
64.

Kobayashi J et al. (1993) A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.

external link
65.

Wood S et al. (1993) Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene.

external link
66.

Pepe G et al. (1994) A new Italian case of lipoprotein lipase deficiency: a Leu365- > Val change resulting in loss of enzyme activity.

external link
67.

Haubenwallner S et al. (1993) A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).

external link
68.

Wilson DE et al. (1993) Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.

external link
69.

Miesenböck G et al. (1993) Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

external link
70.

Mattei MG et al. (1993) Assignment of the human lipoprotein lipase (LPL) gene to chromosome band 8p22.

external link
71.

Ma Y et al. (1993) Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene.

external link
72.

Reymer PW et al. (1995) A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.

external link
73.

Buscà R et al. (1996) The mutation Gly142-->Glu in human lipoprotein lipase produces a missorted protein that is diverted to lysosomes.

external link
74.

Ginzinger DG et al. (1996) A mutation in the lipoprotein lipase gene is the molecular basis of chylomicronemia in a colony of domestic cats.

external link
75.

Weinstock PH et al. (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.

external link
76.

Benlian P et al. (1996) Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.

external link
77.

Henderson HE et al. (1996) A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase.

external link
78.

de Bruin TW et al. (1996) Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.

external link
79.

Wittrup HH et al. (1997) A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.

external link
80.

Mailly F et al. (1997) Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy.

external link
81.

Fisher RM et al. (1997) Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.

external link
82.

Kastelein JJ et al. (1998) The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group.

external link
83.

Nickerson DA et al. (1998) DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene.

external link
84.

Clark AG et al. (1998) Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase.

external link
85.

Henderson HE et al. (1998) Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.

external link
86.

Wittrup HH et al. (1999) Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study.

external link
87.

Boer JM et al. (1999) Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins.

external link
88.

Bertolini S et al. (2000) Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL(Olbia)).

external link
89.

Hoffmann MM et al. (2000) Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.

external link
90.

Samuels ME et al. (2001) Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.

external link
91.

Gilbert B et al. () Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6.

external link
92.

Clee SM et al. (2001) The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease.

external link
93.

Yagyu H et al. (2003) Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

external link
94.

Ling C et al. (2003) Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue.

external link
95.

Yang W et al. (2004) Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees.

external link
96.

López-Miranda J et al. (2004) The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism.

external link
97.

Pruneta-Deloche V et al. (2005) Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.

external link
98.

Goodarzi MO et al. (2005) The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity.

external link
99.

Wittrup HH et al. (2006) Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.

external link
100.

Zhao T et al. (2006) Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.

external link
101.

Frikke-Schmidt R et al. (2007) Subsets of SNPs define rare genotype classes that predict ischemic heart disease.

external link
102.

Goodarzi MO et al. (2007) Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.

external link
103.

Kim MS et al. (2008) Protein kinase D is a key regulator of cardiomyocyte lipoprotein lipase secretion after diabetes.

external link
104.

Kim YJ et al. (2011) Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.

external link
105.

Davies BS et al. (2012) Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

external link
106.

Richardson K et al. (2013) Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site.

external link
107.

Utermann G et al. (1980) Genetics of the apolipoprotein E system in man.

external link
108.

Gregg RE et al. (1981) Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.

external link
109.

Hazzard WR et al. (1981) Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.

external link
110.

Zannis VI et al. (1981) Human apolipoprotein E isoprotein subclasses are genetically determined.

external link
111.

St Clair D et al. (1995) Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers.

external link
112.

Bennett C et al. (1995) Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.

external link
113.

Masliah E et al. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice.

external link
114.

Farrer LA et al. (1995) Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease.

external link
115.

Polvikoski T et al. (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

external link
116.

Levy-Lahad E et al. (1995) Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease.

external link
117.

van Ree JH et al. (1995) Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members.

external link
118.

Nicoll JA et al. (1995) Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.

external link
119.

Matsunaga A et al. (1995) Population frequency of apolipoprotein E5 (Glu3>Lys) and E7 (Glu244>Lys, Glu245-->Lys) variants in western Japan.

external link
120.

Mann WA et al. (1995) Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

external link
121.

Boisvert WA et al. (1995) Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.

external link
122.

van Gool WA et al. (1995) A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.

external link
123.

Kashyap VS et al. (1995) Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.

external link
124.

Mui S et al. (1995) Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.

external link
125.

Osuntokun BO et al. (1995) Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.

external link
126.

Kamboh MI et al. (1995) APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

external link
127.

Tabaton M et al. (1995) Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.

external link
128.

Blennow K et al. (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

external link
129.

Royston MC et al. (1994) Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.

external link
130.

Hyman BT et al. (1995) Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

external link
131.

Strittmatter WJ et al. (1995) Apolipoprotein E and Alzheimer disease.

external link
132.

Lippa CF et al. (1995) Apolipoprotein E genotype and Lewy body disease.

external link
133.

de Knijff P et al. (1994) Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.

external link
134.

Bétard C et al. (1994) Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia.

external link
135.

Linton MF et al. (1995) Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation.

external link
136.

Talbot C et al. (1994) Protection against Alzheimer's disease with apoE epsilon 2.

external link
137.

Corder EH et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

external link
138.

Yoshizawa T et al. (1994) Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.

external link
139.

Lucotte G et al. (1994) Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease.

external link
140.

Kawamata J et al. (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.

external link
141.

Amouyel P et al. (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

external link
142.

Nalbantoglu J et al. (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.

external link
143.

Marder K et al. (1994) The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.

external link
144.

Sanan DA et al. (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.

external link
145.

Frisoni GB et al. (1994) Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease.

external link
146.

Borgaonkar DS et al. (1993) Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19.

external link
147.

None (1993) Apolipoprotein E and Alzheimer's disease.

external link
148.

Poirier J et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease.

external link
149.

Saunders AM et al. (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

external link
150.

Corder EH et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

external link
151.

Saunders AM et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

external link
152.

Strittmatter WJ et al. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

external link
153.

Strittmatter WJ et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

external link
154.

van den Maagdenberg AM et al. (1993) Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.

external link
155.

Garlepp MJ et al. (1995) Apolipoprotein E epsilon 4 in inclusion body myositis.

external link
156.

Lannfelt L et al. (1995) Apolipoprotein epsilon 4 allele in Swedish twins and siblings with Alzheimer disease.

external link
157.

Reiman EM et al. (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

external link
158.

None (1996) Mouse models of atherosclerosis.

external link
159.

Tomimoto H et al. (1995) Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions.

external link
160.

Myers RH et al. (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

external link
161.

Poirier J et al. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

external link
162.

Blesa R et al. (1996) High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.

external link
163.

Tang MX et al. (1996) Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

external link
164.

Payami H et al. (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

external link
165.

Hyman BT et al. (1996) Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual.

external link
166.

Egensperger R et al. (1996) The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.

external link
167.

Slooter AJ et al. (1996) APOE genotyping in differential diagnosis of Alzheimer's disease.

external link
168.

Olichney JM et al. (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant.

external link
169.

Kurz A et al. (1996) Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease.

external link
170.

Growdon JH et al. (1996) Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

external link
171.

Asada T et al. (1996) ApoE epsilon 4 allele and cognitive decline in patients with Alzheimer's disease.

external link
172.

Harrington CR et al. (1995) Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia.

external link
173.

Gerdes LU et al. (1996) The apolipoprotein E polymorphism in Greenland Inuit in its global perspective.

external link
174.

Bickeböller H et al. (1997) Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

external link
175.

Payami H et al. (1997) A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

external link
176.

Oikawa S et al. (1997) Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

external link
177.

Sullivan PM et al. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.

external link
178.

Houlden H et al. (1998) ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.

external link
179.

Sullivan PM et al. (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.

external link
180.

Meyer MR et al. (1998) APOE genotype predicts whennot whetherone is predisposed to develop Alzheimer disease.

external link
181.

Friedman G et al. (1999) Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury.

external link
182.

Kehoe P et al. (1999) Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.

external link
183.

Holtzman DM et al. (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

external link
184.

Wiebusch H et al. (1999) Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.

external link
185.

Teasdale GM et al. (1997) Association of apolipoprotein E polymorphism with outcome after head injury.

external link
186.

Matsunaga A et al. (1999) A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.

external link
187.

McCarron MO et al. (1999) APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis.

external link
188.

Lambert JC et al. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study.

external link
189.

Holtzman DM et al. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

external link
190.

Corbo RM et al. (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?

external link
191.

Raber J et al. (2000) Apolipoprotein E and cognitive performance.

external link
192.

Wiggs JL et al. (2000) Genome-wide scan for adult onset primary open angle glaucoma.

external link
193.

Yaffe K et al. (2000) Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.

external link
194.

Mitchell C et al. (2000) Therapeutic liver repopulation in a mouse model of hypercholesterolemia.

external link
195.

Wang HY et al. (2000) Apolipoprotein E is a genetic risk factor for fetal iodine deficiency disorder in China.

external link
196.

Ishigaki Y et al. (2000) Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice.

external link
197.

Fullerton SM et al. (2000) Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.

external link
198.

Gerdes LU et al. (2000) Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene".

external link
199.

Tangirala RK et al. (2001) Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.

external link
200.

Salero E et al. (2001) Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter.

external link
201.

Knouff C et al. (2001) Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform.

external link
202.

Reynolds WF et al. (2000) MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.

external link
203.

Nguyen TT et al. (2000) Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].

external link
204.

Wang JC et al. (2000) Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

external link
205.

Frikke-Schmidt R et al. (2001) APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease.

external link
206.

Chapman J et al. (2001) APOE genotype is a major predictor of long-term progression of disability in MS.

external link
207.

Bonay P et al. (2001) Apolipoprotein E4 stimulates sulfation of glycosaminoglycans in neural cells.

external link
208.

Peskind ER et al. (2001) Increased CSF cortisol in AD is a function of APOE genotype.

external link
209.

Anderson DH et al. (2001) Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation.

external link
210.

Broderick J et al. (2001) Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke.

external link
211.

Ghebremedhin E et al. (2001) Gender and age modify the association between APOE and AD-related neuropathology.

external link
212.

Zubenko GS et al. (2001) D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.

external link
213.

Mortensen EL et al. (2001) A gender difference in the association between APOE genotype and age-related cognitive decline.

external link
214.

Huang Y et al. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

external link
215.

Lambert JC et al. (2001) Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

external link
216.

Chen G et al. (2001) A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion.

external link
217.

Chapman J et al. (2001) The effects of APOE genotype on age at onset and progression of neurodegenerative diseases.

external link
218.

Sass JO et al. (2001) Increased CSF cortisol in AD is a function of APOE genotype.

external link
219.

Murray BJ et al. (2001) Effects of vagus nerve stimulation on respiration during sleep.

external link
220.

Lesuisse C et al. (2001) Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice.

external link
221.

Goldstein FC et al. (2001) Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.

external link
222.

Bayer AU et al. (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.

external link
223.

Cohen RM et al. (2001) Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women.

external link
224.

Zareparsi S et al. (2002) Age at onset of Parkinson disease and apolipoprotein E genotypes.

external link
225.

Mori E et al. (2002) Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.

external link
226.

Liberman JN et al. (2002) Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury.

external link
227.

Dal Forno G et al. (2002) APOE genotype and survival in men and women with Alzheimer's disease.

external link
228.

Crawford FC et al. (2002) APOE genotype influences acquisition and recall following traumatic brain injury.

external link
229.

Scarmeas N et al. (2002) Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.

external link
230.

Copin B et al. (2002) Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.

external link
231.

Lambert JC et al. (2002) Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.

external link
232.

Verpillat P et al. (2002) Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis.

external link
233.

Wilson RS et al. (2002) The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.

external link
234.

Deary IJ et al. (2002) Cognitive change and the APOE epsilon 4 allele.

external link
235.

Morrow JA et al. (2002) Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease.

external link
236.

Yamauchi T et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

external link
237.

Garcés C et al. (2002) Influence of birth weight on the apo E genetic determinants of plasma lipid levels in children.

external link
238.

Enzinger C et al. (2003) Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

external link
239.

Bennett DA et al. (2003) Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

external link
240.

Schultz DW et al. (2003) Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration.

external link
241.

Ye S et al. (2003) Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study.

external link
242.

Bunce C et al. (2003) Single-nucleotide polymorphisms and glaucoma severity.

external link
243.

Matsumoto S et al. (2003) Modulation of the onset age in primary dystonia by APOE genotype.

external link
244.

Pastor P et al. (2003) Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.

external link
245.

Infante-Rivard C et al. (2003) Small babies receive the cardiovascular protective apolipoprotein epsilon 2 allele less frequently than expected.

external link
246.

Harris FM et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

external link
247.

Qiu C et al. (2003) Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.

external link
248.

Novaro GM et al. (2003) Association between apolipoprotein E alleles and calcific valvular heart disease.

external link
249.

Long JR et al. (2003) APOE and TGF-beta1 genes are associated with obesity phenotypes.

external link
250.

Ressiniotis T et al. (2004) The role of apolipoprotein E gene polymorphisms in primary open-angle glaucoma.

external link
251.

Kantarci OH et al. (2004) Association of APOE polymorphisms with disease severity in MS is limited to women.

external link
252.

Enzinger C et al. (2004) Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

external link
253.

De Stefano N et al. (2004) Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.

external link
254.

Lund G et al. (2004) DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E.

external link
255.

Tiraboschi P et al. (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

external link
256.

Caselli RJ et al. (2004) Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

external link
257.

Li YJ et al. (2004) Apolipoprotein E controls the risk and age at onset of Parkinson disease.

external link
258.

Prince JA et al. (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

external link
259.

Huang X et al. (2004) APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease.

external link
260.

Witsch-Baumgartner M et al. (2004) Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.

external link
261.

Gottlieb DJ et al. (2004) APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study.

external link
262.

Koponen S et al. (2004) APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury.

external link
263.

Bray NJ et al. (2004) Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.

external link
264.

Zwemmer J et al. (2004) Association of APOE polymorphisms with disease severity in MS is limited to women.

external link
265.

Farlow MR et al. (2004) Impact of APOE in mild cognitive impairment.

external link
266.

Ricci R et al. (2004) Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.

external link
267.

Huang W et al. (2004) APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

external link
268.

Blair CK et al. (2005) APOE genotype and cognitive decline in a middle-aged cohort.

external link
269.

Tsuang DW et al. (2005) Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.

external link
270.

Steffens S et al. (2005) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

external link
271.

Dufouil C et al. (2005) APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

external link
272.

Devanand DP et al. (2005) Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

external link
273.

Malek G et al. (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

external link
274.

Seitz A et al. (2005) Sense and antisense transcripts of the apolipoprotein E gene in normal and ApoE knockout mice, their expression after spinal cord injury and corresponding human transcripts.

external link
275.

Faivre L et al. (2005) Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.

external link
276.

O'Hara R et al. (2005) Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.

external link
277.

van den Elzen P et al. (2005) Apolipoprotein-mediated pathways of lipid antigen presentation.

external link
278.

Gureje O et al. (2006) APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

external link
279.

Price DA et al. (2006) Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection.

external link
280.

Ye S et al. (2005) Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

external link
281.

Chang S et al. (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

external link
282.

Babiloni C et al. (2006) Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.

external link
283.

Acciarri A et al. (2006) Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia.

external link
284.

Baird PN et al. (2006) Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD).

external link
285.

Christensen K et al. (2006) The quest for genetic determinants of human longevity: challenges and insights.

external link
286.

Peskind ER et al. (2006) Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.

external link
287.

van der Flier WM et al. (2006) The effect of APOE genotype on clinical phenotype in Alzheimer disease.

external link
288.

Wang JM et al. (2006) Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo.

external link
289.

Busch RM et al. (2007) ApoE-epsilon4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy.

external link
290.

Koutsis G et al. (2007) APOE epsilon4 is associated with impaired verbal learning in patients with MS.

external link
291.

Borroni B et al. (2007) The effect of APOE genotype on clinical phenotype in Alzheimer disease.

external link
292.

Zetterberg M et al. (2007) Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.

external link
293.

Gozal D et al. (2007) APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children.

external link
294.

Lanterna LA et al. (2007) Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia.

external link
295.

Rovin BH et al. (2007) APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.

external link
296.

Donnelly LA et al. (2008) Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.

external link
297.

Allen NC et al. (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

external link
298.

Agosta F et al. (2009) Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

external link
299.

van Vliet P et al. (2009) APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.

external link
300.

Caselli RJ et al. (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

external link
301.

van der Walt A et al. (2009) Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.

external link
302.

Ghaffar O et al. (2010) APOE epsilon4 and the cognitive genetics of multiple sclerosis.

external link
303.

Bell RD et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

external link
304.

Dutta P et al. (2012) Myocardial infarction accelerates atherosclerosis.

external link
305.

Silva F et al. (2013) High apolipoprotein E4 allele frequency in FXTAS patients.

external link
306.

Rhinn H et al. (2013) Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease.

external link
307.

Theendakara V et al. (2013) Neuroprotective Sirtuin ratio reversed by ApoE4.

external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz